Previous close | 1.4700 |
Open | 1.3500 |
Bid | 1.3100 |
Ask | 1.3500 |
Strike | 4.00 |
Expiry date | 2025-01-17 |
Day's range | 1.2900 - 1.3800 |
Contract range | N/A |
Volume | |
Open interest | 83 |
Peloton isn't profitable as a subscription business, but it looks different as a media company.
Amgen is the latest biotech to benefit from obesity drug optimism, Sony and Apollo offer Paramount Global $26 billion cash in takeover move, and other news to start your day.
Amidst leadership transitions and market adjustments, Peloton reports a significant quarter with strategic restructuring and a focus on sustainable growth.